Figure 5.
Survival curve based on first-line treatment subgroups. (A-B) PFS and OS in patients with CLL treated with chemotherapy as first-line treatment. (C-D) PFS and OS in patients with CLL treated with immunochemotherapy. (E-F) PFS and OS in patients with CLL treated with targeted therapy.